Herpes Testing Blog

Congratulations!  You’ve finally decided to stop being ashamed of your genital herpes and address the issue straight on.  Lucky for you, you have some excellent options when it comes to treating genital herpes.

Valtrex is a drug specifically designed to attack herpes straight on.  It has three main uses.  Valtrex works wonders on cold sores, helps prevent outbreaks of genital herpes, and treats herpes Zoster, also known as shingles.  Valtrex is safe for almost anyone to use, except in a few specific cases.  If you’re pregnant, have a weak immune system, or suffering from a kidney problem, ask your doctor before taking Valtrex.  He may prescribe a lower dose, or an alternate medication.  If you’re allergic to acyclovir, you shouldn’t take Valtrex either.  If you’re currently taking probenecid or cimetidine, your doctor may also recommend a lower dosage.  Other than that, though, Valtrex is the perfect solution to your herpes problem.  Valtrex is available with a prescription at your local pharmacy, and generic Valtrex is readily available online.

As soon as you feel that slight tingling sensation on your lips, where you know you’re about to get that nasty looking cold sore, that’s when you know it’s time to break out the Valtrex.  The earlier in the outbreak you take them, the better and more efficiently it works.  That’s why it’s important to have a supply of Valtrex available, even before you feel your next outbreak coming on.  Take 2 grams of Valtrex two times in that first day, and you have a good chance at killing that cold sore before it even comes to the surface.

For genital herpes, you take the full regimen, twice a day for ten days (meaning you need a total of 20 1-gram pills), the first time you have an outbreak, because the first outbreak is usually the most severe.  After that, the next time you feel an outbreak coming on, take two pills, twice a day for three days (a total of six pills), and you can usually pre-empt any future outbreaks.

For more information, please refer to http://www.pro-medics.com/

Pro-medics.com, the online pharmaceutical company, announced their sales addition of the new herpes medication, Generic Valtrex. This innovative drug treatment has just recently become FDA approved for the prevention and treatment of Genital Herpes.

Valtrex is an anti-viral medication that has been medically proven to treat both cold sores and shingles, as well as shorten the length of Herpes treatment time.

Ralphe Rowe, Company Product manager explained, “Unfortunately, Genital Herpes has been currently increasing in appearance amongst the American public, involving a series of embarrassing and uncomfortable symptoms.” “Pro-medics online is proud to offer its customers a discreet and medically effective solution to treating the virus.”

Pro-medics online, offers its clientele free anonymous phone consultations, providing customers with live medical advice and support. This unique form of customer service alleviates the requirement of a prior prescription or potentially embarrassing visit to the doctor.

Pro-medics pharmaceuticals is known for offering its customers first rate service and quality medications at highly discounted prices. The company therefore stocks the preferred generic version of Valacyclovir, otherwise referred to as Generic Valtrex. Generic Valtrex is just as effective as its name brand counterpart, only it’s available at less than half the original drug’s price.

Regarding this decision, Pro-medics President of Sales, Sarah Tenne, explained “Our Company places an emphasis on bringing its customers quality drugs at discount prices. We see no reason for product quality to come at the expense of customer affordability”.

About Pro-Medics
Pro-Medics.com is an online pharmacy website, offering customers popularly prescribed prescription drugs. Pro-Medics also specializes in erectile dysfunction and diet pills, offering a full line of both popular brand name medications as well as their discounted generic counterparts.

For the complete article, please refer to http://www.prweb.com/releases/2009/07/prweb2610284.htm.